Determinant [ftcn]
Bezafibrate [orch, phsu]
Induced [ftcn]
Improvement [cnce]
Cholesterol, LDL [bacs, strd]
Dyslipidaemia [dsyn]
Patients [podg]
Diabetes [dsyn]
subgroup [virs]
Benefit [qnco]
Study [mnob]
Previous [tmco]
Benefit [qnco]
Japan [geoa]
Bezafibrate [orch, phsu]
Effectiveness [qlco]
TOLERABILITY [resa]
Study [mnob]
Bezafibrate [orch, phsu]
blood lipid [lipd]
Profile [lbpr]
GLUCOSE CONTROL [irda]
Dyslipidaemia [dsyn]
Patients [podg]
Diabetes [dsyn]
Bezafibrate [orch, phsu]
Low Density Lipoprotein Cholesterol [bacs, strd]
Patients [podg]
decreases [qnco]
Others [fndg]
increases [ftcn]
subgroup [virs]
Benefit [qnco]
Study [mnob]
Conduct [inbe]
Bezafibrate [orch, phsu]
Induced [ftcn]
Methods [inpr]
Patients [podg]
Benefit [qnco]
Study [mnob]
treated [topp]
Lipid lowering drug [phsu]
Current [tmco]
Study [mnob]
effects [qlco]
treatment [ftcn]
Bezafibrate [orch, phsu]
reduction [npop]
Occurred [acty]
Patients [podg]
Logistic Regression [resa]
Improvement [cnce]
Patients [podg]
Bezafibrate [orch, phsu]
treatment [ftcn]
Increased [qnco]
mg dl [qnco]
treatment [ftcn]
responses [orga]
baseline [bodm]
decreases [qnco]
mg dl [qnco]
Group [idcn]
Decrease [qlco]
mg dl [qnco]
Group [idcn]
mg dl [qnco]
Group [idcn]
Logistic Regression [resa]
Patients [podg]
Identified [qlco]
female sex [fndg]
anti hypertensive [phsu]
Hypoglycemic Agents [phsu]
baseline [bodm]
Determinant [ftcn]
Response [orga]
Bezafibrate [orch, phsu]
Conclusions [idcn]
treatment [ftcn]
Bezafibrate [orch, phsu]
Lipid [lipd]
Profile [lbpr]
Dyslipidaemia [dsyn]
diabetic [fndg]
Patients [podg]
Women [popg]
Subject [grup]
treated [topp]
anti hypertensive [phsu]
Hypoglycemic Agents [phsu]
baseline [bodm]
